Molecular Cytogenetic Aberrations in Thai Patients with Multiple Myeloma Ramathibodi Experience

来源 :The 35th World Congress of the International Society of Hema | 被引量 : 0次 | 上传用户:xuanguiqq110
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
Introduction Cytogenetic abnormality plays an important role in prognosis of patients with multiple myeloma (MM).Conventional cytogenetic assay reveals limited results.In this study,we performed interphase fluorescence in situ hybridization (I-FISH) analysis to explore the incidence of cytogenetic abnormalities in patients with (MM) at Ramathibodi hospital,Bangkok,Thailand.
其他文献
Objective Taliglucerase alfa is the first approved plant cell-expressed recombinant human protein and is an enzyme replacement therapy indicated for treatment of adults with Type 1 Gaucher disease (GD
会议
Background Recurrence is a major cause of treatment failure after allogeneic hematopoietic stem cell transplantation (allo-HSCT) for acute leukemia,and subsequential treatment options are very limited
会议
Objective Imatinib combined with chemotherapy for induction and intensification therapy has be come the standard strategy for Philadelphia-positive acute lymphocytic leukemia (Ph+ALL).Anyhow,intensifi
会议
Objective Chronic renal failure(CRF) patients present with signs of immunodeficiency such as increased incidence of infections.Cell adhesion molecules determining leukocyte migration may be responsibl
会议
Objective Anemia with hypoferremia can be due to either iron deficiency or inflammation.sTfR/log ferritin index is believed to be a biochemical "gold standard" to indicate the iron stores in the body.
会议
Aim To analysis the diversity of inflammation agents expression in the patients of high altitude polycythemia(HAPC).Methods the serum specimen of 20 cases and 20 controls were collected.The serum spec
会议
Background Treatments for multiple myeloma (MM) have dramatically improved now.The immunomodulatory drug (IMiDs) thalidomide and proteasome inhibitor (PI) bortezomib are administrated to patients with
会议
Objective The International Staging System (ISS) is an important prognostic indicator for outcome of patients with multiple myeloma (MM).ISS was proposed in 2005 using data from 10,750 MM patients who
会议
Objective Novel agents-based anti-myeloma regimens including thalidomide and bortezomib have significantly improved myeloma treatment.However,it remains unclear whether patients will benefit more from
会议
Objective High altitude polycythemia (HAPC) is characterized by excessive erythrocytes and enhanced angiogenesis,which is caused by environmental factors such as hypoxia and cold at high altitude.Howe
会议